107. On November 10, 2011, Physician A again saw Patient G for a skin cancer
check, and noted that the spot on Patient G's scalp that was treated with liquid nitrogen
was healing well. Physician A again treated the scalp area with liquid nitrogen.

108. On May 19, 2014, Physician Assistant A performed a shave biopsy of Patient G’s
scalp lesion. The pathology was read as basal cell carcinoma, fragmented.

109. On or about June 16, 2014, the Respondent saw Patient G. She documented
that Patient G had a history of basal cell carcinoma of the right frontal scalp for several
months, and evaluated him for a possible Mohs procedure. '° The Respondent
documented that she presented the treatment options to Patient G, and stated that
“Mohs...surgery which gives a 99+% cure rate ... is reserved for recurrent tumors,
aggressive tumors, or tumors in areas of high recurrence.”

110. On July 7, 2014, the Respondent conducted Mohs surgery on Patient G’s scalp
lesion.

111. The Expert opined that repeated biopsies and/or treatments to the same scalp
lesion were redundant and not clinically indicated.

112. The Respondent was the principal owner of Practice A.

113. The Respondent, as owner of Practice A, received financial benefit from its
providers’ billing.

114. The Respondent's services to Patient G and/or Practice A’s provider services to
Patient G that were redundant or not clinically appropriate as outlined in pertinent part
above, constituted evidence the Respondent engaged in unprofessional conduct and
gross overutilization of health care services.

Patient H

'® Mohs surgery is a precise surgical technique used to treat skin cancer.

29
